A Recap Of My MannKind Experience
Article By:
Trevor Lowenthal
Read
Friday, October 3, 2014 3:31 AM EDT
Various commentators questioned my integrity and motives for my continued coverage of MannKind. This article hopes to set the record straight.
In this article: MNKD
Healthcare Review: FHCO, GOVX, HTBX, ARIA, INCY
Article By:
BioMedReports
Read
Thursday, October 2, 2014 3:38 PM EDT
US stocks fluctuated amid an unexpected decline in jobless claims, while European equities plunged and the euro rose on concern additional stimulus will fail to boost inflation and revive the economy.
Bull Of The Day: Acadia Healthcare
Article By:
Kevin Cook
Read
Thursday, October 2, 2014 11:56 AM EDT
The company exceeded expectations, including a 23% increase in year-over-year EPS on a 20% boost to the top line and an 11.5% jump in same-facility revenue.
In this article: ACHC
Akebia Therapeutics: A Trade Opportunity With A Catalyst Ahead?
Article By:
M.E. Garza
Read
Thursday, October 2, 2014 9:26 AM EDT
With shares trading within a technical range and an upcoming catalyst ahead, it may be time to look for a trade opportunity via Akebia Therapeutics.
In this article: AKBA
Clovis Oncology Should Not Be Ignored
Article By:
Terry Chrisomalis
Read
Tuesday, September 30, 2014 6:10 PM EDT
Clovis announces positive Phase 2 results In Ovarian Cancer patients
In this article: CLVS
Ebola Vs. Us
Article By:
Ilene Carrie
Read
Sunday, September 28, 2014 6:55 PM EDT
Ebola is spreading too quickly for Ebola-vaccine makers to conduct typical studies of safety and efficacy on experimental vaccines. Instead, vaccines will be deployed with protocols devised now, as the situation is worsening daily.
BioLife Elevates Guidance With 130 Embedded Clinical Trials
Article By:
Trevor Lowenthal
Read
Sunday, September 28, 2014 4:48 PM EDT
Overall, I calculate that BioLife is now supported to generate approximately $23 million in revenue by 2018.
In this article: BLFS
Webinar: Trade Like It's A Business
Video By:
Ernie Varitimos
Watch
Friday, September 26, 2014 12:00 PM EDT
Trading success can depend on a number of different variables, just like any business. It's time to treat it like one.
Inovio Pharma Wants To Join The Ebola Party
Article By:
Terry Chrisomalis
Read
Wednesday, September 24, 2014 10:33 PM EDT
Inovio Pharmaceuticals To Begin Ebola Vaccine Study in early 2015